The effect of aspirin on mean platelet volume in patients with paroxysmal atrial fibrillation

References

• Baigent C, Sudlow C, Collins R, Peto R. Collaborative meta-analysis of randomised of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86
   PubMedGoogle Scholar
• Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: Implications of aspirin resistance. J Am Coll Cardiol 2008; 51: 1829–1843
   PubMed Web of Science ®Google Scholar
• Patrono C, Baigent C, Hirsh J, Roth G. Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133: 199–233
   PubMedGoogle Scholar
• Pulcinelli FM, Pignatelli P, Celestini A, Riondino S, Gazzaniga PP, Violi F. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. J Am Coll Cardiol 2004; 43: 979–984
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation?. Curr Pharm Des 2011; 17: 47–58
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD. Platelet function in rheumatoid arthritis: Arthritic and cardiovascular implications. Rheumatol Int 2011; 31: 153–164
   PubMed Web of Science ®Google Scholar
• Colkesen Y, Acil T, Abayli B, Yigit F, Katircibasi T, Kocum T, Demircan S, Sezgin A, Ozin B, Muderrisoglu H. Mean platelet volume is elevated during paroxysmal atrial fibrillation: A marker of increased platelet activation?. Blood Coagul Fibrinolysis 2008; 19: 411–414
   PubMed Web of Science ®Google Scholar
• Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 1986; 17: 622–666
   PubMed Web of Science ®Google Scholar
• Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622–626
   PubMed Web of Science ®Google Scholar
• Muscari A, Puddu GM, Cenni A, Silvestri MG, Giuzio R, Rosati M, Santoro N, Bianchi G, Magalotti D, Zoli M. Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes. Thromb Res 2009; 123: 587–591
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257–e354
   PubMed Web of Science ®Google Scholar
• Lawrence J, Pogue J, Synhorst D, Adalet K, Atar D, Avezum A, Budaj A, Commerford PJ, Dans AL, De Caterina R, Diener HC, Eikelboom J, Connolly SJ, Joyner CD, Hart RG, Lip GY, O'Donnell M, Hohnloser SH, Hankey GJ, Shestakovska O, Yusuf S. AVERROES steering committee and investigators. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurol 2012;11:225–231.
   Google Scholar
• Jagroop IA, Mikhailidis DP. Angiotensin II can induce and potentiate shape change in human platelets: Effect of losartan. J Hum Hypertens 2000; 114: 581–585
   Google Scholar
• Colkesen Y, Muderrisoglu H. The role of mean platelet volume in predicting thrombotic events. Clin Chem Lab Med 2012; 4:631–634.
   Google Scholar
• Gasparyan AY. Aspirin and clopidogrel resistance: Methodological challenges and opportunities. Vasc Health Risk Manag 2010; 6: 109–112
   PubMedGoogle Scholar
• Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005; 46: 284–290
   PubMed Web of Science ®Google Scholar
• De Luca G, Santagostino M, Secco GG, Cassetti E, Giuliani L, Franchi E, Coppo L, Iorio S, Venegoni L, Rondano E, et al. Mean platelet volume and the extent of coronary artery disease: Results from a large prospective study. Atherosclerosis 2009; 206: 292–297
   PubMed Web of Science ®Google Scholar
• Aksu H, Ozer O, Unal H, Hobikoglu G, Norgaz T, Buturak A, Soylu O, Narin A. Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes. Blood Coagul Fibrinolysis 2009; 20: 686–693
   PubMedGoogle Scholar
• Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M, Dong JF, Kleiman NS, Guthikonda S. Platelet activation patterns in platelet size sub-populations: Differential responses to aspirin in vitro. Thromb Thrombolysis 2010; 30: 251–262
   PubMed Web of Science ®Google Scholar
• Erhart S, Beer JH, Reinhart WH. Influence of aspirin on platelet count and volume in humans. Acta Haematol 1999; 101: 140–144
   PubMed Web of Science ®Google Scholar
• Huczek Z, Filipiak KJ, Kochman J, Michalak M, Roik M, Piatkowski R, Grabowski M, Postula M, Opolski G. Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study. Thromb Res 2010; 125: 406–412
   PubMedGoogle Scholar
• Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, Granada JF, Dong JF, Kleiman NS, Lev EI. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 743–749
   PubMed Web of Science ®Google Scholar